Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novocure Ltd Ord Sh (NVCR)

Novocure Ltd Ord Sh (NVCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting

Novocure (NASDAQ: NVCR) today announced 43 presentations on Tumor Treating Fields will be featured at the Society for Neuro-Oncology 2020 Virtual Annual Meeting on November 19 through November 21. The...

NVCR : 134.32 (+1.48%)
With Growing Incidence of Brain Cancer The Brain Tumor Drug Market Could Reach $3.4 Billion in 2022

, /PRNewswire/ -- With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of diagnosis and treatment of brain tumors...

CNSP : 2.32 (+3.11%)
AMRN : 4.51 (-2.38%)
ATHE : 1.6300 (+1.87%)
BMY : 61.40 (-0.34%)
NVCR : 134.32 (+1.48%)
Novocure Receives CE Mark for NovoTTF-100L(TM) System

Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced that it has received the CE Mark for the NovoTTF-100L system...

NVCR : 134.32 (+1.48%)
Novocure Announces Agenda for Virtual Research and Development Day

Novocure (NASDAQ: NVCR) today announced the agenda for the company's virtual Research and Development Day for analysts and investors from 7:30 a.m. to 9:30 a.m. EST on Thursday, November 12, 2020. The...

NVCR : 134.32 (+1.48%)
Novocure Announces Closing of $150 Million Revolving Credit Facility with a Syndicate of Relationship Banks

Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced the closing of a new $150 million senior secured revolving...

NVCR : 134.32 (+1.48%)
Novocure Ltd Shares (NVCR)

SmarTrend identified a Downtrend for Novocure Ltd (NASDAQ:NVCR) on October 22nd, 2020 at $127.63. In approximately 2 weeks, Novocure Ltd has returned 1.09% as of today's recent price of $126.24.

NVCR : 134.32 (+1.48%)
After Yesterday's Rally of 4.43% Shares Could Potentially Pullback

Novocure Ltd (NASDAQ:NVCR) traded in a range yesterday that spanned from a low of $121.75 to a high of $128.13. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of...

NVCR : 134.32 (+1.48%)
Novocure Announces Closing of $575 Million 0% Convertible Senior Notes Private Placement

Novocure (NASDAQ: NVCR), a global oncology company striving to extend survival in some of the most aggressive forms of cancer, today announced the closing of its previously announced offering of $575 million...

NVCR : 134.32 (+1.48%)
Novocure Prices $500 Million 0% Convertible Senior Notes Private Placement

Novocure (NASDAQ:NVCR), a global oncology company striving to extend survival in some of the most aggressive forms of cancer, today announced the pricing of $500 million aggregate principal amount of its...

NVCR : 134.32 (+1.48%)
Novocure Announces Proposed Private Placement of $500 Million of Convertible Senior Notes

Novocure (NASDAQ: NVCR), a global oncology company striving to extend survival in some of the most aggressive forms of cancer, today announced its intention to offer $500 million aggregate principal amount...

NVCR : 134.32 (+1.48%)
Novocure Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 29, 2020 / Novocure Ltd. (NASDAQ:NVCR) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 29, 2020 at 8:00 AM...

NVCR : 134.32 (+1.48%)
Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update

--Quarterly net income of $9.3 million with $0.09 in earnings per share

NVCR : 134.32 (+1.48%)
Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research

Novocure (NASDAQ: NVCR) today announced it has entered into a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and...

NVCR : 134.32 (+1.48%)
4 Overvalued Stocks to Avoid for the Rest of 2020

Valuations for stocks such as Datadog (DDOG), DraftKings (DKNG), NovoCure (NVCR), and Chegg (CHGG) look stretched. The company's current and expected financials fail to justify their valuations. Its best...

DDOG : 91.21 (+2.38%)
DKNG : 48.27 (+0.08%)
NVCR : 134.32 (+1.48%)
CHGG : 71.51 (+0.69%)
NVE Schedules Conference Call on Second-Quarter Results

NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter and six months ended September 30, 2020 on Wednesday, October 21, 2020 after the close of the Nasdaq...

NVCR : 134.32 (+1.48%)
NVEC : 52.62 (+0.75%)
Kroger, Hyatt Hotels, ResMed, LHC Group and NovoCure highlighted as Zacks Bull and Bear of the Day

Kroger, Hyatt Hotels, ResMed, LHC Group and NovoCure highlighted as Zacks Bull and Bear of the Day

RMD : 209.21 (-0.86%)
H : 71.75 (+3.94%)
KR : 33.03 (+1.82%)
LHCG : 199.31 (-2.38%)
NVCR : 134.32 (+1.48%)
3 Large-Cap MedTech Growth Stocks to Buy Amid the Pandemic

Let's take a look at three large-cap MedTech stocks that are currently flourishing on the back of a number of positive developments.

MASI : 245.04 (-1.18%)
RMD : 209.21 (-0.86%)
ABT : 108.97 (-1.73%)
TMO : 445.06 (-1.33%)
LHCG : 199.31 (-2.38%)
NVCR : 134.32 (+1.48%)
Jabil, Harley-Davidson, TMO, LHCG and NovoCure as Zacks Bull and Bear of the Day

Jabil, Harley-Davidson, TMO, LHCG and NovoCure as Zacks Bull and Bear of the Day

JBL : 38.12 (+1.84%)
HOG : 39.99 (+7.59%)
TMO : 445.06 (-1.33%)
LHCG : 199.31 (-2.38%)
NVCR : 134.32 (+1.48%)
3 Growth-Focused MedTech Stocks to Buy Amid the COVID-19 Crisis

Here are three growth stocks from the MedTech space which have maintained stellar performance even during the pandemic-led market meltdown.

RMD : 209.21 (-0.86%)
TMO : 445.06 (-1.33%)
LHCG : 199.31 (-2.38%)
NVCR : 134.32 (+1.48%)
Is NovoCure (NVCR) Outperforming Other Medical Stocks This Year?

Is (NVCR) Outperforming Other Medical Stocks This Year?

NVCR : 134.32 (+1.48%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar